78
39
Growth Score 78 in past quarter
-7 pts
Heat Score 39 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
874898
Cyclenium Pharma is an emerging biotechnology company.
- Helmut Thomas: Founder, President and CEO
About the Company
Cyclenium Pharma is a pharmaceutical r and d company exploiting its next-generation macrocyclic drug discovery technology to identify novel small molecule therapeutics for difficult disease targets in areas of unsatisfied medical need. It is creating value through a progression of internal programs in oncology, infectious diseases, and
inflammation/pain. It is providing its extensive experience and exploring its CMRT-based QUEST™ screening library in risk-sharing partnerships with academic and research-driven non-profit organizations as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas.
